Cargando…

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer

Ubiquitin and ubiquitin-related proteins posttranslationally modify substrates, and thereby alter the functions of their targets. The ubiquitination process is involved in various physiological responses, and dysregulation of components of the ubiquitin system has been linked to many diseases includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masoumi, K. C., Shaw-Hallgren, Gina, Massoumi, Ramin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246786/ https://www.ncbi.nlm.nih.gov/pubmed/22235375 http://dx.doi.org/10.1155/2011/614097

Ejemplares similares

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
por: Hövelmeyer, Nadine, et al.
Publicado: (2007)

Nonmelanoma Skin Cancer
por: Samarasinghe, Venura, et al.
Publicado: (2012)

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
por: Wickström, Sara A, et al.
Publicado: (2010)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

Targeted Therapy in Nonmelanoma Skin Cancers
por: Spallone, Giulia, et al.
Publicado: (2011)

Botanical Agents for the Treatment of Nonmelanoma Skin Cancer
por: Millsop, Jillian W., et al.
Publicado: (2013)

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009)

Nonmelanoma Skin Cancer on the Rise
por: Wollina, Uwe
Publicado: (2012)

The Danish Nonmelanoma Skin Cancer Dermatology Database
por: Lamberg, Anna Lei, et al.
Publicado: (2016)

Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway
por: Liang, Gang, et al.
Publicado: (2011)

Association of Nuclear-Localized Nemo-Like Kinase with Heat-Shock Protein 27 Inhibits Apoptosis in Human Breast Cancer Cells
por: Shaw-Hallgren, Gina, et al.
Publicado: (2014)

CASPASE 8 inhibits programmed necrosis by processing CYLD
por: O’Donnell, Marie Anne, et al.
Publicado: (2011)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023)

CLINICOPATHOLOGICAL EVALUATION OF NONMELANOMA SKIN CANCER
por: Adinarayan, Manjula, et al.
Publicado: (2011)

Potential role for the tumor suppressor CYLD in brain and notochord development
por: Li, Te, et al.
Publicado: (2021)

Novel Medical Strategies Combating Nonmelanoma Skin Cancer
por: Bhandari, Prasan R, et al.
Publicado: (2014)

Teledermatology: From Prevention to Diagnosis of Nonmelanoma and Melanoma Skin Cancer
por: Fabbrocini, G., et al.
Publicado: (2011)

Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
por: Matthey-Giè, Marie-Laure, et al.
Publicado: (2013)

NONMELANOMA SKIN CANCER IN INDIA: CURRENT SCENARIO
por: Panda, Saumya
Publicado: (2010)

An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
por: Perera, Eshini, et al.
Publicado: (2013)

Density of Langerhans Cells in Nonmelanoma Skin Cancers: A Systematic Review
por: Pogorzelska-Dyrbuś, Joanna, et al.
Publicado: (2020)

Herpes vegetans on the shoulder mimicking nonmelanoma skin cancer
por: Ho, Bao Vincent K., et al.
Publicado: (2022)

CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production
por: Nishanth, Gopala, et al.
Publicado: (2013)

Diet and Skin Cancer: The Potential Role of Dietary Antioxidants in Nonmelanoma Skin Cancer Prevention
por: Katta, Rajani, et al.
Publicado: (2015)

Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy
por: Kasper, Michael E, et al.
Publicado: (2015)

The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
por: Campione, Elena, et al.
Publicado: (2015)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Nonmelanoma skin cancer in women [Image: see text]
por: Heaton, H., et al.
Publicado: (2018)

The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
por: Ahmed, Neesar, et al.
Publicado: (2011)

The Value of Mohs Surgery for the Treatment of Nonmelanoma Skin Cancers
por: Alcalay, Joseph
Publicado: (2012)

Nonmelanoma Skin Cancer with Skull Infiltration and Cranial Involvement
por: Wollina, Uwe, et al.
Publicado: (2019)

Validation of claims data algorithms to identify nonmelanoma skin cancer
por: Eide, Melody J., et al.
Publicado: (2012)

Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995–1999
por: Stang, A, et al.
Publicado: (2003)

Nonmelanoma skin cancer in Saudi Arabia: single center experience
por: AlSalman, Sarah Abdullah, et al.
Publicado: (2018)

Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
por: Ghahartars, Mehdi, et al.
Publicado: (2018)

Sex‐specific differences in patients with nonmelanoma skin cancer of the pinna
por: Moser, Ulrich, et al.
Publicado: (2020)

Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure
por: Nicoletti, Giovanni, et al.
Publicado: (2020)

Risk of Nonmelanoma Skin Cancers and Parkinson’s Disease—Meta-Analysis and Systematic Review
por: Krasowska, Danuta, et al.
Publicado: (2021)

Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer
por: Jaberi, Ramin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6kojjrf8g89sqpudu9as7cjj3g